Hemopure South Africa
OPK Biotech websites
AN AFFILIATE OF HbO2 Therapeutics LLC
Hemopure® was approved in 2001 by the MCC for the treatment of adult surgical patients who are acutely anaemic. Hemopure is indicated for the purpose of eliminating, delaying or reducing the need for allogenic red blood cells.
Tel +27 126 643 994
Laboratory Values Reference Guide
Information for monitoring patients after Hemopure administration. Covers haematology, clinical monitoring, serum chemistry, coagulation, and urinalysis.
Read about our technology